Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Vergunst, H."" wg kryterium: Autor


Tytuł :
Functional and oncological outcomes of salvage cryosurgery for radiorecurrent prostate cancer.
Autorzy :
Exterkate L; Department of Urology, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands.
Peters M; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
Somford DM; Department of Urology, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands.
Vergunst H; Department of Urology, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands.
Pokaż więcej
Źródło :
BJU international [BJU Int] 2020 Oct 11. Date of Electronic Publication: 2020 Oct 11.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Value of Serial Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging-guided Biopsies in Men with Low-risk Prostate Cancer on Active Surveillance After 1 Yr Follow-up.
Autorzy :
Hamoen EHJ; Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; Department of Radiology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Hoeks CMA; Department of Radiology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Somford DM; Department of Urology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.
van Oort IM; Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Vergunst H; Department of Urology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands.
Oddens JR; Department of Urology, Jeroen Bosch Hospital, Den Bosch, The Netherlands.
Smits GA; Department of Urology, Alysis Zorggroep, Arnhem, The Netherlands.
Bokhorst LP; Department of Urology, Erasmus University Medical Centre, Rotterdam, The Netherlands.
Witjes JA; Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Rovers MM; Department of Operating Rooms, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; Department of Health Evidence, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Hulsbergen-van de Kaa CA; Department of Pathology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Barentsz JO; Department of Radiology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. Electronic address: .
Pokaż więcej
Źródło :
European urology focus [Eur Urol Focus] 2019 May; Vol. 5 (3), pp. 407-415. Date of Electronic Publication: 2018 Jan 10.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Biopsy/*methods
Magnetic Resonance Imaging, Interventional/*methods
Multiparametric Magnetic Resonance Imaging/*methods
Prostate/*pathology
Prostatic Neoplasms/*pathology
Watchful Waiting/*methods
Aged ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Neoplasm Grading ; Prostate/diagnostic imaging ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/diagnosis ; Prostatic Neoplasms/diagnostic imaging
Czasopismo naukowe
Tytuł :
Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score.
Autorzy :
Van Neste L; Department of Pathology, Maastricht University Medical Center, Maastricht, The Netherlands.
Hendriks RJ; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Dijkstra S; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Trooskens G; MDxHealth BV, Nijmegen, The Netherlands.
Cornel EB; Department of Urology, ZGT Hospital, Hengelo, The Netherlands.
Jannink SA; MDxHealth BV, Nijmegen, The Netherlands.
de Jong H; MDxHealth BV, Nijmegen, The Netherlands.
Hessels D; MDxHealth BV, Nijmegen, The Netherlands.
Smit FP; MDxHealth BV, Nijmegen, The Netherlands.
Melchers WJ; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands.
Leyten GH; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Urology, AMC University Medical Centre, Amsterdam, The Netherlands.
de Reijke TM; Department of Urology, AMC University Medical Centre, Amsterdam, The Netherlands.
Vergunst H; Department of Urology, CWZ Hospital, Nijmegen, The Netherlands.
Kil P; Department of Urology, St. Elisabeth Hospital, Tilburg, The Netherlands.
Knipscheer BC; Department of Urology, Scheper Hospital, Emmen, The Netherlands.
Hulsbergen-van de Kaa CA; Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
Mulders PF; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
van Oort IM; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Van Criekinge W; Department of Mathematical Modelling, Statistics and Bioinformatics, Ghent University, Ghent, Belgium.
Schalken JA; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: .
Pokaż więcej
Źródło :
European urology [Eur Urol] 2016 Nov; Vol. 70 (5), pp. 740-748. Date of Electronic Publication: 2016 Apr 20.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Prostatic Neoplasms*/pathology
Prostatic Neoplasms*/therapy
Prostatic Neoplasms*/urine
RNA, Messenger*/analysis
RNA, Messenger*/urine
Homeodomain Proteins/*genetics
Medical Overuse/*prevention & control
Transcription Factors/*genetics
Aged ; Biomarkers, Tumor/genetics ; Clinical Decision-Making/methods ; Humans ; Male ; Middle Aged ; Neoplasm Grading ; Patient Selection ; Prostate/pathology ; Prostate-Specific Antigen/analysis ; Reproducibility of Results ; Research Design ; Risk Assessment/methods ; Risk Factors
Czasopismo naukowe
Tytuł :
Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker-Based Risk Score
Autorzy :
Neste, L. Van
Hendriks, R.J.
Dijkstra, S.
Trooskens, G.
Cornel, E.B.
Jannink, S.A.
Jong, H. de
Hessels, D.
Smit, F.P.
Melchers, W.J.G.
Leyten, G.
Reijke, T.M. de
Vergunst, H.
Kil, P.
Knipscheer, B.C.
Kaa, C.A. van de
Mulders, P.F.A.
Oort, I.M. van
Criekinge, W. van
Schalken, J.A.
Pokaż więcej
Temat :
Logistic models
Prostate neoplasms
Urine
Messenger RNA
Biologic markers
PSA
Źródło :
European urology, 70(5), 740 - 748. Elsevier
European Urology, 70, 740 - 748
European Urology, 70(5), 740 - 748. Elsevier
Opis pliku :
application/pdf
Tytuł :
Does a decision aid for prostate cancer affect different aspects of decisional regret, assessed with new regret scales? A randomized, controlled trial.
Autorzy :
van Tol-Geerdink JJ; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
Leer JW; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
Wijburg CJ; Department of Urology, Rijnstate Hospital, Arnhem, the Netherlands.
van Oort IM; Department of Urology, Radboud University Medical Center, Nijmegen, the Netherlands.
Vergunst H; Department of Urology, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands.
van Lin EJ; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.
Witjes JA; Department of Urology, Radboud University Medical Center, Nijmegen, the Netherlands.
Stalmeier PF; Department of Health Evidence, Radboud University Medical Center, Nijmegen, the Netherlands.
Pokaż więcej
Źródło :
Health expectations : an international journal of public participation in health care and health policy [Health Expect] 2016 Apr; Vol. 19 (2), pp. 459-70. Date of Electronic Publication: 2015 May 03.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Validation Study
MeSH Terms :
Decision Support Techniques*
Emotions*
Patient Participation/*psychology
Prostatic Neoplasms/*therapy
Aged ; Analysis of Variance ; Choice Behavior ; Humans ; Male ; Middle Aged ; Prostatic Neoplasms/mortality ; Prostatic Neoplasms/psychology ; Quality of Life
Czasopismo naukowe
Tytuł :
383 Multicenter validation study of a urine-based molecular biomarker algorithm to predict high-grade prostate cancer.
Autorzy :
Hendriks, R.J.
Dijkstra, S.
Trooskens, G.
Van Criekinge, W.
Cornel, E.B.
Jannink, S.A.
De Jong, H.
Hessels, D.
Smit, F.P.
Melchers, W.J.G.
Leyten, G.H.J.M.
De Reijke, T.M.
Vergunst, H.
Kil, P.
Knipscheer, B.C.
Hulsbergen-Van De Kaa, C.A.
Mulders, P.F.A.
Van Oort, I.M.
Van Neste, L.
Schalken, J.A.
Pokaż więcej
Źródło :
European Urology Supplements. Mar2016, Vol. 15 Issue 3, pe383,e383a-e383,e383a. 1p.
Czasopismo naukowe
Tytuł :
Identification of a Candidate Gene Panel for the Early Diagnosis of Prostate Cancer.
Autorzy :
Leyten GH; Radboud University Nijmegen Medical Centre, Department of Urology, Nijmegen, the Netherlands.
Hessels D; Noviogendix, Department of Research and Development, Nijmegen, the Netherlands.
Smit FP; Noviogendix, Department of Research and Development, Nijmegen, the Netherlands.
Jannink SA; Noviogendix, Department of Research and Development, Nijmegen, the Netherlands.
de Jong H; Noviogendix, Department of Research and Development, Nijmegen, the Netherlands.
Melchers WJ; Radboud University Nijmegen Medical Centre, Department of Urology, Nijmegen, the Netherlands. Noviogendix, Department of Research and Development, Nijmegen, the Netherlands.
Cornel EB; ZGT Hospital, Department of Urology, Hengelo, the Netherlands.
de Reijke TM; AMC University Medical Centre, Department of Urology, Amsterdam, the Netherlands.
Vergunst H; CWZ Hospital, Department of Urology, Nijmegen, the Netherlands.
Kil P; St Elisabeth Hospital, Department of Urology, Tilburg, the Netherlands.
Knipscheer BC; Scheper Hospital, Department of Urology, Emmen, the Netherlands.
Hulsbergen-van de Kaa CA; Radboud University Nijmegen Medical Centre, Department of Pathology, Nijmegen, the Netherlands.
Mulders PF; Radboud University Nijmegen Medical Centre, Department of Urology, Nijmegen, the Netherlands.
van Oort IM; Radboud University Nijmegen Medical Centre, Department of Urology, Nijmegen, the Netherlands.
Schalken JA; Radboud University Nijmegen Medical Centre, Department of Urology, Nijmegen, the Netherlands. Noviogendix, Department of Research and Development, Nijmegen, the Netherlands. .
Pokaż więcej
Źródło :
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2015 Jul 01; Vol. 21 (13), pp. 3061-70. Date of Electronic Publication: 2015 Mar 18.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Biomarkers, Tumor/*urine
Prostatic Neoplasms/*diagnosis
Adult ; Aged ; Aged, 80 and over ; Biomarkers, Tumor/genetics ; Carrier Proteins/genetics ; Carrier Proteins/urine ; Cell Cycle Proteins ; Early Detection of Cancer ; Homeodomain Proteins/genetics ; Homeodomain Proteins/urine ; Humans ; Male ; Middle Aged ; Neoplasm Grading ; Prostatic Neoplasms/genetics ; Prostatic Neoplasms/urine ; Quinolines ; ROC Curve ; Transcription Factors/genetics ; Transcription Factors/urine ; Transcriptome
Czasopismo naukowe
Tytuł :
Pharmacokinetic, Pharmacodynamic, and Activity Evaluation of TMX-101 in a Multicenter Phase 1 Study in Patients With Papillary Non-Muscle-Invasive Bladder Cancer.
Autorzy :
Arends TJ; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Lammers RJ; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Falke J; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
van der Heijden AG; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Rustighini I; Telormedix SA, Bioggio, Switzerland.
Pozzi R; Telormedix SA, Bioggio, Switzerland.
Ravic M; Pharma Integra Ltd, Wimbledon, London, England, UK.
Eisenhardt A; Pur/r Praxisklinik Urologie, Nordrhein-Westfalen, Germany.
Vergunst H; Department of Urology, Canisius-Wilhelmina Ziekenhuis, Nijmegen, The Netherlands.
Witjes JA; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: .
Pokaż więcej
Źródło :
Clinical genitourinary cancer [Clin Genitourin Cancer] 2015 Jun; Vol. 13 (3), pp. 204-9.e2. Date of Electronic Publication: 2014 Dec 31.
Typ publikacji :
Clinical Trial, Phase I; Journal Article; Multicenter Study
MeSH Terms :
Aminoquinolines/*administration & dosage
Antineoplastic Agents/*administration & dosage
Carcinoma, Renal Cell/*drug therapy
Kidney Neoplasms/*drug therapy
Administration, Intravesical ; Aminoquinolines/adverse effects ; Aminoquinolines/pharmacokinetics ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/pharmacokinetics ; Carcinoma, Renal Cell/pathology ; Carcinoma, Renal Cell/surgery ; Cystoscopy ; Dose-Response Relationship, Drug ; Female ; Humans ; Imiquimod ; Interleukin 1 Receptor Antagonist Protein/urine ; Kidney Neoplasms/pathology ; Kidney Neoplasms/surgery ; Male ; Middle Aged ; Prospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Incremental value of transition zone and midline apical biopsy at baseline TRUS-guided biopsy for prostate cancer detection.
Autorzy :
Somford DM; Department of Urology (B28), Canisius-Wilhelmina Hospital, Weg door Jonkerbos 100, 6532 SZ, Nijmegen, The Netherlands, .
Vreuls W
Jansen TS
van Basten JP
Vergunst H
Pokaż więcej
Źródło :
World journal of urology [World J Urol] 2014 Apr; Vol. 32 (2), pp. 461-7. Date of Electronic Publication: 2013 Jul 20.
Typ publikacji :
Journal Article
MeSH Terms :
Biopsy, Large-Core Needle/*methods
Prostate/*pathology
Prostatic Neoplasms/*pathology
Adult ; Aged ; Aged, 80 and over ; Cohort Studies ; Humans ; Image-Guided Biopsy ; Kallikreins/blood ; Male ; Middle Aged ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/blood ; Retrospective Studies ; Ultrasonography, Interventional
Czasopismo naukowe
Tytuł :
957 Role of repeat 3T multiparametric MR imaging and MR-guided biopsy versus repeat TRUS-guided biopsies after 1 year follow-up in low-risk prostate cancer patients in an active surveillance protocol.
Autorzy :
Hamoen, E.H.J.
Hoeks, C.
Somford, D.M.
Van Oort, I.M.
De Hulsbergen-Van Kaa, C.A.
Vergunst, H.
Oddens, J.R.
Smits, G.A.
Bangma, C.H.
Barentsz, J.O.
Witjes, J.A.
Pokaż więcej
Źródło :
European Urology Supplements. Apr2014, Vol. 13 Issue 1, pe957-e957. 1p.
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies